Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis (COAST_UAcCNV)
Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis
Sponsor: Central Polyclinic of Internal Affairs of Ukraine
This NA trial investigates Chorioretinitis and is currently ongoing. Central Polyclinic of Internal Affairs of Ukraine leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Mar 2021 — Mar 2023 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central Polyclinic of Internal Affairs of Ukraine
- Mykolaiv Region Ophthalmogical Hospital
- Odessa National Medical University
- The Filatov Institute of Eye Diseases and Tissue Therapy
For direct contact, visit the study record on ClinicalTrials.gov .